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Abstract
During dermal injury and inflammation the serine pro-
teases kallikreins cleave endogenous, multifunctional
substrates (kininogens) to form bradykinin and kallidin.
The actions of kinins are mediated by preferential binding
to constitutively expressed kinin-B2 receptors or induci-
ble kinin-B1 receptors. A feature of the kinin-B1 recep-
tors is that they show low levels of expression, but are
distinctly upregulated following tissue injury and inflam-
mation. Because recent evidence suggested that kinin-
B1 receptors may perform a protective role during
inflammation, we investigated the specific occurrence of
the kallikrein-kinin components in skin biopsies obtained
from normal skin, patients undergoing surgery, basalio-
ma, lichenificated atopic eczema, and psoriasis. The tis-
sue was immunolabelled in order to determine the
localisation of tissue pro-kallikrein, kallikrein, kininogen
and kinin receptors. The kinin components were visuali-
sed in normal, diseased and traumatised skin, except
that no labelling was observed for kininogen in normal
skin. Of the five types of tissue examined, upregulation
of kinin-B1 receptors was observed only in skin biopsies
obtained following surgery. In essence, the expression of
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kinin-B1 receptors did not appear to be enhanced in the
other biopsies. Within the multiple steps of the inflam-
matory cascade in wound healing, our results suggest an
important regulatory role for kinin-B1 receptors during
the first phase of inflammation following injury.
Keywords: basalioma (basal cell carcinoma);
inflammation; kinin-B1 receptor upregulation;
lichenificated atopic eczema; psoriasis.
Introduction
Kinins are vasoactive peptides that are considered to
play a primary role in inflammatory processes. Kinins are
formed by the serine proteases kallikreins, which cleave
high- and low-molecular-weight kininogens. The biolog-
ical actions of kinins include smooth muscle contraction,
vasodilation, release of inflammatory mediators, plasma
extravasation, leukocyte diapedesis, and activation of
sensory neurons (Bhoola et al., 1992). Vasodilation,
increased vascular permeability and pain perception are
distinct inflammatory events produced by injected bra-
dykinin. Kinins act functionally on the circulation as
endogenous vasodilator and hypotensive mediators. Of
interest also is the co-mitogen property of kinins in the
cellular proliferation of keratinocytes (Schremmer-
Danninger et al., 1995). The effects of kinin peptides are
mediated by interaction with pharmacologically distinct
receptor types, namely the kinin-B2 and -B1 receptors
(Regoli and Barabe´, 1980). The kinin-B1 receptor is pref-
erentially activated by the kinins that lack the C-terminal
Arg residue: des-Arg10-kallidin and des-Arg9-bradykinin,
whereas the kinin-B2 receptor is selective for the parent
molecules, namely bradykinin and kallidin. The physio-
logically prominent, constitutive kinin-B2 receptor has
certainly been the subject of intensive investigation in
drug development, structure-function activity and func-
tional studies. However, during tissue injury when acti-
vated by kinin-B1 agonists, the expression of the
kinin-B1 receptor is rapidly upregulated. Such an
induced expression is an unusual feature for a G protein-
coupled receptor (Marceau et al., 1998). This is the first
study that demonstrates the expression and upregulation
of kinin-B1 receptor following trauma in the tissues of
human skin. We also demonstrate the localisation of
kinin-B2 receptor and the proform and mature protein of
tissue kallikrein in normal human skin. An additional aim
of our study was to localise components of the kallikrein-
kinin cascade in selected skin diseases: psoriasis, liche-
nificated atopic eczema and basalioma.
The results obtained with traumatised skin were com-
pared with those of dermal diseases of the human skin.
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Results
Rationale for the study
In particular, children undergoing heart surgery that
involves extracorporeal circulation may suffer from mas-
sive oedema during the first 24 h following surgery. The
fluid extravasation may represent a kinin-induced effect,
since such an action has been shown to occur both in
an animal model (Neppl et al., 1991) and in children
undergoing cardiopulmonary bypass surgery (Neuhof et
al., 2003). The data reported by Neppl et al. (1991) sug-
gest that bradykinin-induced oedema is regulated by the
kinin-B2 receptor, and is potentiated by simultaneous
stimulation of kinin-B1 receptors. Neuhof et al. (2003)
stated that bradykinin appears to be essential for the
enhancement of microvascular permeability, although a
dominant causal role cannot be claimed. An additional
question we wished to clarify was whether the changes
in cellular orientation and localisation of the kallikrein-
kinin proteomes in the traumatised skin differed from
those observed in dermal diseases.
Expressed proteins of the kallikrein-kinin cascade were
immunolabelled in biopsies of the human skin following
injury and in dermal diseases, using specific antibodies.
A synopsis is shown in Table 1.
Kinin-B2 receptor
Specific staining for kinin-B2 receptor proteins was found
in keratinocytes of the basal layer of the epidermis, and
in fibroblasts of the dermis of normal human skin (Figure
1E). It was also observed in endothelial cells of vessels
and in sweat gland cells. Only psoriatic skin biopsies and
carcinoma cells of basalioma revealed almost no staining
for kinin-B2 receptors. Within the traumatised or dis-
eased skin no change of expression was discernible.
Kinin-B1 receptor
In all biopsies of diseased skin and of normal skin the
kinin-B1 receptor was detected at a very low level, with
minimal staining in keratinocytes and fibroblasts (not
shown). Sweat gland cells showed higher receptor
expression compared to keratinocytes or fibroblasts as
visualised here for normal skin (Figure 2A) and lichenifi-
cated atopic eczema (Figure 2B). In the surgically trau-
matised skin biopsies obtained from adult patients who
had undergone a heart operation, analysis of labelling of
kinin-B1 receptor proteins using quantitative confocal
laser scanning microscopy revealed up to 15-fold upre-
gulation of expression within epidermal keratinocytes
after the operation. Figure 1A,B shows results for a 67-
year-old patient.
The mean"SEM for all immunofluorescence images
analysed for adult biopsies (age 63.5"8.5 yr) was slightly
lower than for the best example shown: epidermis at the
beginning of surgery (2.8"2.0)=102 pixels/mm2, and at
the end of surgery (25.7"8.2)=102 pixels/mm2.
In children the upregulation was only up to three-fold,
and was observed mainly within the subepidermal layers.
Figure 1C,D shows results for the 3.5-year-old child.
The mean"SEM for the immunofluorescence images
analysed for biopsies from children (ages 3 yr and
3 months"1 yr and 5 months) for the subepidermal lay-
ers was (11.8"3.7)=102 pixels/mm2 at the beginning of
surgery, and (24.0"5.3)=102 pixels/mm2 at the end of
surgery.
Tissue kallikrein
In normal skin and in biopsies from lichenificated atopic
eczema, basalioma and psoriasis tissue, kallikrein could
be visualised by antibody binding in basal keratinocytes
and in some keratinocytes of the stratum spinosum of
the epidermis, in fibroblasts of the dermis and in sweat
gland cells. As an example, tissue kallikrein immunoreac-
tivity within the basal keratinocytes of normal skin is
shown in Figure 3A and in lichenificated atopic eczema
in Figure 3B.
Tissue pro-kallikrein
In all skin biopsies, positive immunostaining could be
shown for basal keratinocytes, fibroblasts and sweat
gland cells; less staining was visualised in the keratino-
cytes of the stratum spinosum. Only minimal staining or
no labelling was evident in the fibroblasts of lichenificated
atopic eczema. Anti-tissue pro-kallikrein antibody label-
ling in the cells of sweat glands of normal skin is shown
in Figure 2C, lichenificated atopic eczema in Figure 2D,
and keratinocytes of the basal, mitotic active epidermal
layer of lichenificated atopic eczema in Figure 3C.
Kininogen
A granular-type of staining deposit with a monoclonal
anti-bradykinin antibody, which labels the kinin moiety in
the intact kininogen molecule, was evident in the dermis
of the basalioma biopsy (Figure 3D), and in the sweat
gland ducts of basalioma (Figure 2E) and traumatised
skin (Figure 2F). In the epidermis of surgically traumatised
skin biopsies, an evenly distributed positive immuno-
reaction was imaged by FITC immunofluorescence (Fig-
ure 3E).
Discussion
Generalised alteration in permeability with the develop-
ment of interstitial oedema is a frequent consequence of
extracorporeal circulation in paediatric heart surgery and
is considered to be related to the circulating levels of
kinins. As kinins are known to increase the permeability
of blood vessels, the activation of the kallikrein-kinin sys-
tem and its potential role in the pathogenesis of this intra-
and postoperative complication was investigated by
Neuhof et al. (2003). In patients with a disruption of fluid
balance, resulting in oedema, a significantly higher con-
centration of bradykinin in blood samples was found. The
increase in the concentration of bradykinin was paralleled
by fluid retention of more than 6% of body weight during
bypass and a 2-day postoperative period. A 10- to 20-
fold increase in bradykinin during the first 10 min of car-
diopulmonary bypass operation was also reported by
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Table 1 Immunolocalisation of components of the kallikrein-kinin system in normal, traumatised and diseased skin.
Traumatised skin Normal skin Psoriasis Basalioma Lichenificated
Child Adult atopic eczema
Kinin-B1 Subepidermal Epidermal Epidermala As normal skin As normal skin As normal skin
receptor layers layers keratinocytes (Figure 2B)
upregulated upregulated Dermal
(Figure 1C,D) (Figure 1A,B) fibroblasts
Sweat gland
cells
(Figure 2A)
Kinin-B2 Basal Basal Basal As normal skin, As normal skin, As normal skin
receptor keratinocytes keratinocytes keratinocytes except no except no
Fibroblasts Fibroblasts (Figure 1E) staining of staining of
Dermal keratinocytes carcinoma cells
fibroblasts
Endothelial
cells of
vessels
Sweat gland
cells
Tissue Not evaluated Not evaluated Basal Only in Keratinocytes Basal
kallikrein keratinocytes keratinocytes keratinocytes
(Figure 3A) Fibroblasts (Figure 3B)
Keratinocytes Fibroblasts
of stratum
spinosum
Fibroblasts
Sweat gland
cells
(Figure 2C)
Tissue Not evaluated Not evaluated Basal As normal skin As normal skin Basal
pro-kallikrein keratinocytes keratinocytes
Keratinocytes (Figure 3C)
of stratum No staining of
spinosum fibroblasts
Dermal Sweat gland
fibroblasts cells
Sweat gland (Figure 2D)
cells
Kininogen No distinct Infiltrated No distinct Weak around Granular-type As basalioma
staining plasma in staining fibroblasts staining
epidermal deposited
layers in the stratum
(Figure 3E) spinosum of
Sweat gland epidermis and
cells sweat gland
(Figure 2F) cells (Figures 3D and 2E)
aKinin-B1 receptor was found in epidermal keratinocytes and dermal fibroblasts at low levels and in sweat glands at higher levels.
Campbell et al. (2001). The authors measured circulating
kinin and kallikrein levels and concluded that activation
of the kallikrein-kinin system was indicated.
Since evidence suggests that kinin-B1 receptors may
exert a protective role during inflammation, the aim of our
study was to investigate the specific occurrence of kinin-
B1 receptors in skin biopsies obtained from patients
undergoing heart surgery. The question we asked was
whether kinin receptor expression in the skin was altered
at the beginning and end of surgery. Image analysis of
immunofluorescent labelling in the same adult patient
(ns6) showed an up to 15-fold upregulation of the kinin-
B1 receptor in skin biopsies obtained subsequent to
heart surgery when compared to the beginning of surgery
(Figure 1A,B). However, in children (ns3) an up to three-
fold upregulation was evident, mainly in the subepidermal
layer (Figure 1C,D), thereby contributing to the disruption
of fluid balance observed.
Only in children does a marked degree of fluid reten-
tion and oedema in paediatric cardiopulmonary bypass
surgery result in delayed chest closure because of mas-
sive chest wall oedema, which returns to normal within
hours after the end of surgery. Elevated blood concen-
trations of bradykinin can be observed during extracor-
poreal circulation (Neuhof et al., 2003). The
approximately three-fold upregulation of kinin-B1 recep-
tors (Figure 1C,D) evident within the subepidermal layers
of the skin seems to contribute to the disruption of fluid
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Figure 1 Visualisation of kinin receptors.
(A–D) Kinin-B1-receptor upregulation within epidermis and der-
mis. Immunovisualisation of kinin-B1 receptor upregulation in
(A,B) adult skin and (C,D) in skin obtained from children during
heart surgery. Biopsies were obtained at the beginning and at
the end of surgery. White arrows point to the outside of the skin
with the horny layer. Images from a confocal laser scanning
microscope show on the left a skin section cut from a biopsy
resected at the beginning of surgery and during extracorporeal
circulation. On the right a section cut from a biopsy resected at
the end of surgery is shown. The intensity of the colour-coded
immunofluorescence, given as greyscale values representing the
relative amount of kinin-B1 receptors, is depicted on the colour
strip, with red-white as maximum wpurple-blueszero; green-yel-
low (greyscale phases 89–121)smoderate; red-white (greyscale
phases 155–256)smaximum; for precise greyscale values refer
to the followingx. (A,B) Confocal laser scanning images of adult
skin. Colour-coded immunofluorescence intensity within greys-
cale phases 155–256 for the epidermis: (A) (2.1"1.3)=102 pixels/
mm2 (beginning of surgery); and (B) (31.4"1.8)=102 pixels/mm2
(end of surgery). (C,D) Confocal laser scanning images of skin
obtained from a child. Colour-coded immunofluorescence inten-
sity within grey scale phases 155–256 for the subepidermal lay-
er: (C) (10.5"4.1)=102 pixels/mm2 (beginning of surgery); and (D)
(28.3"4.8)=102 pixels/mm2 (end of surgery). (E) Localisation of
kinin-B2 receptors in the epidermis of normal skin. Arrows point
to the specifically immunolabelled kinin-B2 receptors, shown as
a stained line of basal keratinocytes; above this line are the next
layers of the epidermis and below this line of stained keratino-
cytes is the dermis with specifically stained fibroblasts (*). Coun-
terstaining was performed with hematoxylin-eosin. Scale bar,
10 mm.
balance observed. Biopsies from three children at the
ages of 10 months, 3.5 and 5.5 yr showed almost the
same degree of upregulation, of between 2.0- and 2.8-
fold.
The upregulation of kinin-B1 receptors during the oper-
ation within adult epidermis at the site of the operation
wound seems to represent a local inflammatory response
in wound healing, along with local oedema limited to the
site of surgical injury. The upregulation of kinin-B1 recep-
tors ranged between approximately eight- and 15-fold
within biopsies of selected adults. Figure 1A,B shows the
best example of upregulation within the epidermis of a
67-year-old adult.
Whereas in children the upregulation of kinin-B1 recep-
tors might represent one factor contributing to marked
oedema in cardiopulmonary bypass surgery, the massive
upregulation in adults seems to demonstrate the role of
kinin-B1 receptors in wound healing.
The striking comparison between children and adults
in this study involves not only the extent of upregulation,
but also the site of upregulation of kinin-B1 receptors.
This upregulation could be visualised within the subepi-
dermal layers in skin biopsies of children, contributing to
oedema, whereas in adult skin the epidermis itself was
the site of upregulation of kinin-B1 receptors and might
represent its involvement in the beginning of wound
healing.
Oedema caused by enhanced capillary permeability
may have been mediated through kinin-B1 receptors by
the in situ formation of kinin-B1 receptor agonist mole-
cules, formed as a result of the simultaneous upregula-
tion of carboxypeptidase M. The upregulation of kinin-B1
receptors may be a functional response to antagonise
the detrimental effects of the parent kinins, namely bra-
dykinin and kallidin (Neuhof et al., 2003), but possibly
also of as yet unknown factors.
From the results of this study, we can assess that in
the very first stage after an injury the upregulation of
kinin-B1 receptors induces the first step of the kallikrein-
kinin cascade. These upregulated receptors might play a
major role in a physiological protective mechanism that
can contribute to wound healing as part of a repair mech-
anism in adult skin. Concerning the generalised oedema,
the upregulation of expression observed in subepidermal
skin of children may be part of an over-reaction and/or
over-regulation to counteract possible inflammatory
reactions.
Rawlingson et al. (2001) reported the rapid involvement
of the kinin-B1 receptor in murine skin in microvascular
response to burn injury, indicating that these receptors
play an essential role in mediating the early rather than
the delayed phase of oedema formation, as well as not-
ing neutrophil accumulation in their experiments. This
result may also be due to protective reactions and under-
lines our finding of upregulated kinin-B1 receptors in
traumatised skin, but not in biopsies of chronic skin dis-
eases, in which an upregulation of kinin-B1 receptors
could not be found. In biopsies of diseased skin (psori-
asis, basalioma and lichenificated atopic eczema) no
upregulation could be shown. Our finding that the kinin-
B1 receptor protein is expressed in normal skin at quite
low levels and that the kinin-B1 receptor gene is consti-
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Figure 2 Immunovisualisation of kinin-B1 receptor, tissue pro-kallikrein and kininogen in sweat gland cells of normal skin, licheni-
ficated atopic eczema and of traumatised skin.
Arrows point to the expression of the appropriate visualised protein. (A) Kinin-B1 receptor labelled sites in normal skin; (B) kinin-B1
receptor labelling in lichenificated atopic eczema; (C) tissue pro-kallikrein labelled sites in normal skin; (D) tissue pro-kallikrein labelled
sites in lichenificated atopic eczema; (E) kininogen (anti-kinin antibody) staining in a biopsy of basalioma (scale bar, 50 mm); (F)
kininogen (anti-kinin antibody) labelled in traumatised skin with fluorescent conjugated antibody (scale bar, 50 mm); the arrow points
to a basement membrane; below and to the right of the star, whole cells are stained. For panels (A–E) light microscopy using the
peroxidase-antiperoxidase streptavidin-biotin conjugated system was performed, with counterstaining using hematoxylin-eosin. Scale
bar length is 10 mm unless otherwise stated.
tutively expressed in normal skin (Schremmer-Danninger
et al., 1999) agrees with studies by Chai et al. (1996),
who also showed kinin-B1 receptor gene expression in
various normal human tissues. Our results suggest an
important regulatory role for the kinin-B1 receptor within
the multiple steps of the cascade necessary for the pos-
itive inflammatory processes in wound healing.
For the constitutively expressed kinin-B2 receptor, no
differences were observed in the localisation or amount
of labelling between the skin biopsies of patients with
dermal diseases, except for psoriatic skin, in which no
labelling was evident for kinin-B2 receptors in the basal
keratinocytes, and for basalioma biopsies, in which car-
cinoma cells were not labelled by anti-kinin-B2 receptor
antibody. This finding may be due to an exceptionally
high replication rate, with a late ‘thinning out’ of kinin-B2
receptors. One view of the enhanced mitogenic activity
of the basal keratinocytes in psoriasis may be that kinin-
B2 receptors are functionally active at the onset of a
lesion, but not in the chronic state. In healthy skin, kinin-
B2 receptors could be shown in the basal, mitotically
active layer of keratinocytes within the epidermis (Figure
1E). The immunolabelled images are in harmony with
those previously demonstrated by receptor microauto-
radiography (Schremmer-Danninger et al., 1995).
In all biopsies investigated in this study, the cellular
kinin-B2 receptor (Figure 1E), tissue kallikrein and tissue
pro-kallikrein (Figure 3A,B,C) could be visualised, as also
demonstrated at the RNA level by Schremmer-Danninger
et al. (1999); these components of the kallikrein-kinin
system could be demonstrated despite kininogen in nor-
mal skin.
Kininogen could be shown in biopsies of basalioma in
sweat gland cells (Figure 2E) and in papillary dermis (Fig-
ure 3D), as well as in sweat gland cells of traumatised
skin (Figure 2F) and in traumatised epidermis (Figure 3E).
In the papillary dermis a granular-type of staining deposit
was found, whereas within epidermis traumatised by sur-
gery, evenly distributed staining with the fluorescent con-
jugated antibody could be shown. Considering the
importance of leakage of plasma into the epidermis dur-
ing inflammatory reactions, comprising kininogen, kallidin
and bradykinin, this might be the source of ligands for
the upregulated kinin-B1 receptors. Whereas in adult
patients the leakage of plasma seems to be confined to
the epidermal layers, as shown in our study, in children
a generalised disturbance of microvascular permeability
with marked oedema and effusions takes place as a sig-
nificant complication of cardiopulmonary bypass (Neuhof
et al., 2003). On the other hand, it seems that in chronic
disease infiltrating neutrophils represent a source of kini-
nogen (Figure 3D).
A molecular response to infection, tissue injury and
proliferation of tumour cells is the secretion of chemo-
tactic molecules that attract neutrophils to sites of inflam-
mation. They interact through the surface anchoring of
integrin molecules with endothelial cells, and by the pro-
cess of diapedesis migrate through capillary gap junc-
tions to gain access into the interstitial tissue space. IL-
1b, TNF-a and bradykinin induced inflammatory-cell
neutrophil migration in a rat air-pouch model (Santos et
al., 2003). This migration could be markedly reduced by
the appropriate inhibitors. Neutrophils bear kininogen
(Figueroa et al., 1992, 1999) and neutrophils contain the
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Figure 3 Localisation of (A) tissue kallikrein in normal skin, (B) tissue kallikrein and (C) tissue pro-kallikrein in lichenificated atopic
eczema, and (D) kininogen in basalioma and (E) traumatised adult skin.
Examples for normal, traumatised and diseased skin biopsies are depicted. Tissue kallikrein and tissue pro-kallikrein are both localised
in basal mitotically active keratinocytes, as visualised by light microscopy using the peroxidase-antiperoxidase streptavidin-biotin
conjugated method. The antibody against tissue kallikrein, as well as the antibody against tissue pro-kallikrein, immunoreacted
intensely with almost every keratinocyte of the mitotic active layer within the epidermis (see arrows). Anti-tissue kallikrein antibody
also reacted with some of the keratinocytes of the stratum spinosum; see staining close to the asterisk in (A). Counterstaining was
performed with hematoxylin-eosin. (D) Localisation of kininogen in a basalioma biopsy. Sections of basalioma revealed a granular-
type of staining deposits found in the papillary dermis (see arrows). Labelling was performed with the anti-kinin antibody, which
detects the kinin moiety in the kininogen molecule. Counterstaining was done with hematoxylin-eosin. (E) Localisation of the kinin
moiety in traumatised adult skin. The image shows the highest distribution of staining (FITC immunofluorescence) throughout the
epidermal layer between the two asterisks. The arrow points to the outside of the skin. Scale bar, 10 mm.
complete system for the synthesis and release of bioac-
tive kinins (Bockmann and Paegelow, 2000). In the
inflammatory cells of diseased skin, neutrophils attracted
by cytokines are a source of kininogen. The granular-type
of staining deposit may reflect neutrophil clusters, where-
as the evenly distributed staining in traumatised epider-
mis might show ligands bound to evenly distributed
kinin-B1 receptors. The kininogen antibody detects the
kinin moiety, including des-Arg-kinins.
Poblete et al. (1991) showed the cellular localisation of
immunoreactive tissue kallikrein and kininogen in human
sweat glands. In our study, kinin-B1 receptors and tissue
pro-kallikrein could be immunovisualised in normal skin
sweat gland cells (Figure 2A, C). In traumatised skin, anti-
kininogen antibody reacted with the basement mem-
branes of sweat gland cells (Figure 2F). The full
complement of a functionally active kallikrein-kinin sys-
tem is also present in these human sweat gland cells,
which might represent active stimulation of the gland.
Whether this stimulation is related to an inflammatory
status and its role within these reactions cannot be dis-
cussed here. In their paper, Poblete et al. (1991) pro-
posed that an increase in mitotic activity in psoriatic
epidermis is a possible effect of kinins.
Taken together, our results suggest an important reg-
ulatory role for kinin-B1 receptors during the first stage
of inflammation following an injury within the cascade of
inflammatory processes in wound healing. The full com-
plement of a functionally active kallikrein-kinin system is
observed, when under pathological conditions kininogen
arises from non-pre-existing sources.
Materials and methods
Ethical permission
Permission to obtain biopsies of human skin was obtained from
the appropriate University Ethics Committee (Ludwig-Maximi-
lians-University, Munich and Justus-Liebig-University, Giessen)
authorised to review human studies. Written consent was
obtained from each patient enrolled in the study. Special care
was taken in the case of children, and consent was obtained
from the parent or guardian, as required.
Tissue samples and fixation
Small skin biopsies were obtained from 9 patients at the age of
10 months, 3.5, 5.5, 45, 58, 67, 68, 70 and 73 yr, undergoing
heart operations, at the beginning and at the end of surgery.
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Histologically normal adult skin was obtained from areas sur-
rounding dermal naeve excised for suspicion of melanoma;
biopsies from typical forms of psoriatic skin, lichenificated atopic
eczema and basalioma were taken before treatment from two
patients with their permission.
Biopsies were immediately fixed in 5% cold, freshly prepared
paraformaldehyde for 24 h, dehydrated in a graded series of
ethanol, cleared in xylene and embedded in paraffin. Serial sec-
tions (3 mm) were cut on a Leitz microtome, mounted onto adhe-
sive-coated (poly-L-lysine, Sigma Chemical Co, St. Louis, USA)
glass slides and were used for visualisation of kinin receptors
by immunocytochemistry.
Antibodies
Anti-kinin-B1 receptor antibodies A mixture of antibodies
(AS 367–375) directed to various specific sequences of the
human kinin-B1 receptor raised in rabbits was provided by W.
Mu¨ller-Esterl (Johann-Wolfgang-Goethe-University, Frankfurt,
Germany) and used at dilutions ranging from 1:100 to 1:1000.
Anti-kinin-B2 receptor antibodies Of the eight polyclonal
antibodies fully characterised for specificity, raised against syn-
thetic peptides of the amino-terminal and loop regions encoded
by the rat kinin-B2 receptor cDNA and based on the homoge-
neity between these regions with the human receptor, the four
that reacted strongly with human epithelial cells and neutrophils
(Haasemann et al., 1994) were chosen to perform the localisa-
tion experiments. A combination of antibodies was chosen: Leu-
His-Lys-Thr-Asn-Cys-Thr-Val-Ala-Glu for intracellular domain 1
(ID1, LHK, 280) (L-H-K-T-N-C-T-V-A-E for ID1); Asp-Arg-Tyr-Leu-
Ala-Leu-Val-Lys-Thr-Met-Ser-Met-Gly-Arg-Met for intracellular
domain 2 (ID2, DRT, 277) (D-R-Y-L-A-L-V-K-T-M-S-M-G-R-M for
ID2); and Asp-Thr-Leu-Leu-Arg-Leu-Gly-Val-Leu-Ser-Gly-Cys
for the fourth extracellular domain (ED4, DTL, 283) (D-T-L-L-R-
L-G-V-L-S-G-C for ED4). These antibodies were kindly provided
by W. Mu¨ller-Esterl (Johann-Wolfgang-Goethe-University,Frank-
furt, Germany) and were used at a dilution of 1:500.
Anti-kininogen antibodies A monoclonal mouse anti-bra-
dykinin antibody (donated by M. Webb, Sandoz, UK) was used
to immunolabel the kinin moiety in the intact kininogen molecule.
Anti-tissue kallikrein and pro-kallikrein antibodies Both
antibodies were prepared as reported previously (Kemme et al.,
1999; Naidoo et al., 1999). Specific antiserum for tissue kallikrein
was produced in goat using purified recombinant tissue kalli-
krein. Since this antibody was raised against the mature recom-
binant enzyme, it detected both the active form and the proform
of the enzyme. The IgG fraction was isolated from the antibody
to recombinant tissue kallikrein, and used for immunolabelling
at a 1:100 dilution. To generate an antibody that discriminated
between the active form and proform of tissue pro-kallikrein, the
peptide Cys-Ala1-Pro-Pro-Ile-Gln-Ser-Arg7-Ile-Val-Gly10, cov-
ering the amino-terminus of tissue pro-kallikrein, was used. An
additional Cys-residue was introduced at the amino-terminus of
the synthesised peptide to facilitate coupling to the carrier-pro-
tein keyhole limpet haemocyanin. This conjugate was used for
the production of tissue pro-kallikrein anti-sera in rabbits and
the isolated IgG was used at 1:100 dilution for the immunola-
belling experiments.
Secondary antibodies The appropriate anti-species anti-
body IgG, conjugated with either peroxidase or fluorescein, was
used as the sandwich antibody.
Immunolabelling controls In order to assess the specificity
of the immunolabelling, method controls were prepared in which
each primary antibody was replaced by either buffer (PBS) or
non-immune serum.
Immunocytochemistry
Light microscopy peroxidase-antiperoxidase streptavidin-
biotin conjugated system Slides with the mounted skin tis-
sue sections were placed on a heating mantle until the wax
melted and were then dewaxed in xylene. Tissue was rehydrated
through a series of increasingly dilute ethanol solutions and then
placed in distilled water as the final rehydrant. Between the 90%
and 70% ethanol hydration steps, tissue had to be immersed in
absolute methanol for 25 min to quench endogenous peroxidase
activity.
Moderate boiling in 0.01 M Na-citrate buffer (pH 6.0) for 8 min
at 808C followed for antigen retrieval in a Sharp R-4A52 micro-
wave oven. Then the tissue was allowed to cool to room tem-
perature and placed again in distilled water. Before incubating
in 10% H2O2/95% methanol (v/v) for 20 min at room temperature
to quench endogenous peroxidases a second time, the tissue
had to be washed once in 0.01 M PBS/1% BSA to reduce non-
specific binding and then twice in 0.01 M PBS. The incubation
with the first antibody, diluted in maleic acid/10% milk blocker
in PBS (Boehringer, Mannheim, Germany) took place overnight
at 48C in a humidified chamber. After two washing steps with
0.01 M PBS, the tissue on the slides was treated with the per-
oxidase-antiperoxiodase streptavidin-biotin conjugating system
(LSAB K0690, DAKO, Hamburg, Germany) for 20 min each, with
PBS wash steps in between. The labelled antibody bound to the
peroxidase-antiperoxiodase immuno-enzyme complex was
visualised by incubating with liquid diaminobenzidine (DAB) pre-
cipitant (K3468, DAKO) for up to 4 min in the dark. Tissues were
counterstained with Mayer’s haematoxylin. Sections were then
dehydrated and mounted in a permanent medium (Entellan;
Merck, Darmstadt, Germany) and immunovisualised by conven-
tional light microscopy under a Nikon photomicroscope.
FITC immunofluorescence Wax-embedded tissue sections
mounted on silanised slides were processed in the same way
as described for the light microscopy peroxidase anti-peroxi-
dase method, except for the H2O2 step. Before incubation with
the first antibody (diluted in 10% milk blocker) overnight at 48C
in a humid chamber, a blocking step of 10 min at room tem-
perature in 10% milk blocker was included to reduce non-spe-
cific binding.
After incubating with the first antibody, tissue was washed in
0.01 M PBS and incubated for 30 min at room temperature with
anti-species fluorescent conjugate (anti-rabbit IgG FITC conju-
gate F1262, Sigma). After a washing step with 0.01 M PBS,
aqueous mounting with 10% PBS/90% glycerol or DAKO fluoro-
mount was carried out. Specific fluorescence emitted by the
fluorophore coupled to the secondary antibody could be
inspected in a fluorescence microscope (Nikon photomicro-
scope with fluorescence detection system) and was then visua-
lised, colour-coded and quantified with a confocal laser
scanning microscope (Leica TD4, Leica, Solms, Germany).
Analysis of immunofluorescence images The amount of
kinin-B1 receptors was computed and colour-coded by image
analysis. The mean intensity of immunolabelling was quantified
in pixels=102/mm2 using the Analysis 2.1 Pro system (Soft-Imag-
ing Software GmbH, Mu¨nster, Germany). Confocal images were
typically recorded at a density of 225=225 pixels. The grey scale
ranged from 0 to 256, and was divided into 8 equal phases (POLI
Look-Up-Table), with each phase having a lower and upper grey-
scale value threshold. Using the Analysis 2.1 Pro system, the
regions of interest for each image were encircled. Each encircled
specified tissue area was used to calculate the number of pixels
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falling within each phase in the area analysed. Therefore, the
mean intensity of immunolabelling in specific areas was quan-
tified in pixels/mm2 (Snyman et al., 1999).
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